Elekta AB (publ) - Asset Resilience Ratio

Latest as of January 2026: 9.18%

Elekta AB (publ) (EKTA-B) has an Asset Resilience Ratio of 9.18% as of January 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

Skr2.54 Billion
≈ $273.45 Million USD Cash + Short-term Investments

Total Assets

Skr27.68 Billion
≈ $2.98 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2012–2025)

This chart shows how Elekta AB (publ)'s Asset Resilience Ratio has changed over time. Check EKTA-B strategic asset allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Elekta AB (publ)'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Elekta AB (publ) (EKTA-B) market capitalisation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Skr2.54 Billion 9.18%
Short-term Investments Skr0.00 0%
Total Liquid Assets Skr2.54 Billion 9.18%

Asset Resilience Insights

  • Limited Liquidity: Elekta AB (publ) maintains only 9.18% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Elekta AB (publ) Industry Peers by Asset Resilience Ratio

Compare Elekta AB (publ)'s asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Edwards Lifesciences Corp
NYSE:EW
Medical Devices 9.20%
DexCom Inc
NASDAQ:DXCM
Medical Devices 19.55%
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033
Medical Devices 19.31%
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A
SHG:688212
Medical Devices 6.09%
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
Medical Devices 10.88%
Theradiag SA
PA:ALTHE
Medical Devices 15.59%
Corentec Co Ltd
KQ:104540
Medical Devices 2.80%
Adherium Ltd
AU:ADR
Medical Devices 15.45%

Annual Asset Resilience Ratio for Elekta AB (publ) (2012–2025)

The table below shows the annual Asset Resilience Ratio data for Elekta AB (publ).

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-04-30 10.20% Skr2.96 Billion
≈ $318.01 Million
Skr28.98 Billion
≈ $3.12 Billion
+3.24pp
2024-04-30 6.96% Skr2.19 Billion
≈ $235.14 Million
Skr31.41 Billion
≈ $3.38 Billion
-0.64pp
2023-04-30 7.60% Skr2.25 Billion
≈ $242.14 Million
Skr29.61 Billion
≈ $3.19 Billion
-4.10pp
2022-04-30 11.70% Skr3.08 Billion
≈ $331.13 Million
Skr26.30 Billion
≈ $2.83 Billion
-1.07pp
2021-04-30 12.77% Skr3.17 Billion
≈ $341.36 Million
Skr24.84 Billion
≈ $2.67 Billion
-5.63pp
2020-04-30 18.40% Skr5.23 Billion
≈ $562.62 Million
Skr28.41 Billion
≈ $3.06 Billion
+8.42pp
2019-04-30 9.98% Skr2.40 Billion
≈ $258.49 Million
Skr24.06 Billion
≈ $2.59 Billion
+1.81pp
2018-04-30 8.17% Skr1.83 Billion
≈ $197.37 Million
Skr22.46 Billion
≈ $2.42 Billion
+2.09pp
2017-04-30 6.08% Skr1.27 Billion
≈ $137.00 Million
Skr20.95 Billion
≈ $2.25 Billion
+7.87pp
2016-04-30 -1.80% Skr-349.00 Million
≈ $-37.56 Million
Skr19.44 Billion
≈ $2.09 Billion
-0.12pp
2015-04-30 -1.67% Skr-354.00 Million
≈ $-38.10 Million
Skr21.18 Billion
≈ $2.28 Billion
-45.02pp
2012-04-30 43.35% Skr6.60 Billion
≈ $710.70 Million
Skr15.23 Billion
≈ $1.64 Billion
--
pp = percentage points

About Elekta AB (publ)

ST:EKTA-B Sweden Medical Devices
Market Cap
$1.91 Billion
Skr17.76 Billion SEK
Market Cap Rank
#6215 Global
#92 in Sweden
Share Price
Skr48.38
Change (1 day)
-0.74%
52-Week Range
Skr42.38 - Skr63.25
All Time High
Skr125.13
About

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers linear accelerator and radiation therapy products comprising Elekta Unity for anatomy-specific MR imaging; Elekta Evo that delivers offline and online adaptive radiation therapy; Elekta Versa … Read more